|
CN111763178A
|
|
Nitrooxazine crystal form, preparation method and application
|
|
US2019218192A1
|
|
Trifluoroacetyl hydrazide compounds and medical uses thereof
|
|
CN111617047A
|
|
Pharmaceutical composition containing TBN or TBN salt or TBN hydrate salt and preparation method of pharmaceutical composition
|
|
CN108379270A
|
|
A kind of ligustrazine derivant is preparing the application in preventing and treating anti-parkinson drug
|
|
WO2018036080A1
|
|
Application of amino adamantane mononitrate in preparing drug for preventing and treating disease
|
|
WO2017190526A1
|
|
Application of tetramethylpyrazine derivative tetramethylpyrazine nitrone in prevention and treatment of brain injury diseases
|
|
US2018148404A1
|
|
Amantadine nitrate compounds with neural protective effect, and preparation and medical use thereof
|
|
US2018147181A1
|
|
Use of andrographolide derivatives in preparation of medicaments for preventing and treating inflammatory bowel diseases
|
|
CA2991338A1
|
|
New pyrazine derivative, and preparation method and medical application thereof
|
|
US2018346430A1
|
|
Trifluoroacetyl hydrazide compounds and methods of preparation and uses thereof
|
|
EP3150574A1
|
|
Amantadine nitrate compound having a neuroprotective effect and preparation and medical use thereof
|
